Valoctocogene Roxaparvovec gene therapy for Hemophilia A.
21 Mar, 2022 | 08:27h | UTCValoctocogene Roxaparvovec Gene Therapy for Hemophilia A – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries:
Valoctocogene Roxaparvovec Evaluated in Severe Hemophilia A – HealthDay
Hemophilia A Gene Therapy Reduced Bleeding Events, Need for Clotting Factors – AJMC